Paper40202170
Plasma-Derived Exosomal i-tRF-LeuCAA as Biomarker for Glioma Diagnosis and Promoter of Epithelial-Mesenchymal Transition via TPM4 Regulation.
Liu H and 5 others. CNS Neurosci Ther, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Plasma-Derived Exosomal i-tRF-LeuCAA as Biomarker for Glioma Diagnosis and Promoter of Epithelial-Mesenchymal Transition via TPM4 Regulation. Papers, record 40202170. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40202170
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasma-Derived Exosomal i-tRF-LeuCAA as Biomarker for Glioma Diagnosis and Promoter of Epithelial-Mesenchymal Transition via TPM4 Regulation.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioma | Major topic |
| Epithelial-Mesenchymal Transition | Major topic |
| Exosomes | Major topic |
| Biomarkers, Tumor | Major topic |
| Brain Neoplasms | Major topic |
| Tropomyosin | Major topic |
| Humans | |
| Animals | |
| Male | |
| Cell Line, Tumor | |
| Female | |
| Mice | |
| Mice, Nude | |
| Middle Aged | |
| Mice, Inbred BALB C |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82303586 | National Natural Science Foundation of China | PubMed | ||
| 82373220 | National Natural Science Foundation of China | PubMed | ||
| 82473264 | National Natural Science Foundation of China | PubMed |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30987208 | Proteomic Analysis Implicates Vimentin in Glioblastoma Cell Migration. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/30987208 | PubMed |
| 2 | 37430089 | Emerging roles of tRNA-derived small RNAs in cancer biology. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37430089 | PubMed |
| 3 | 36072386 | Identification of Novel tRNA-Leu-CAA-Derived tsRNAs for the Diagnosis and Prognosis of Diffuse Gliomas. | Cancer Manag Res | 2022 | https://conductscience.org/library/papers/36072386 | PubMed |
| 4 | 30862693 | HERC3-Mediated SMAD7 Ubiquitination Degradation Promotes Autophagy-Induced EMT and Chemoresistance in Glioblastoma. | Clin Cancer Res | 2019 | https://conductscience.org/library/papers/30862693 | PubMed |
| 5 | 30380423 | Large Differences in Small RNA Composition Between Human Biofluids. | Cell Rep | 2018 | https://conductscience.org/library/papers/30380423 | PubMed |
| 6 | 29337107 | tRNA-derived small non-coding RNAs in human disease. | Cancer Lett | 2018 | https://conductscience.org/library/papers/29337107 | PubMed |
| 7 | 27936807 | tRNA-Derived RNA Fragments Associate with Human Multisynthetase Complex (MSC) and Modulate Ribosomal Protein Translation. | J Proteome Res | 2017 | https://conductscience.org/library/papers/27936807 | PubMed |
| 8 | 31127834 | Prediction of IDH genotype in gliomas with dynamic susceptibility contrast perfusion MR imaging using an explainable recurrent neural network. | Neuro Oncol | 2019 | https://conductscience.org/library/papers/31127834 | PubMed |
| 9 | 19933153 | A novel class of small RNAs: tRNA-derived RNA fragments (tRFs). | Genes Dev | 2009 | https://conductscience.org/library/papers/19933153 | PubMed |
| 10 | 22885326 | RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis. | Nat Struct Mol Biol | 2012 | https://conductscience.org/library/papers/22885326 | PubMed |
| 11 | 39037259 | Optimizing of a suitable protocol for isolating tissue-derived extracellular vesicles and profiling small RNA patterns in hepatocellular carcinoma. | Liver Int | 2024 | https://conductscience.org/library/papers/39037259 | PubMed |
| 12 | 30849983 | The role of exosomal noncoding RNAs in cancer. | Mol Cancer | 2019 | https://conductscience.org/library/papers/30849983 | PubMed |
| 13 | 23812729 | Tropomyosin-4 correlates with higher SBR grades and tubular differentiation in infiltrating ductal breast carcinomas: an immunohistochemical and proteomics-based study. | Tumour Biol | 2013 | https://conductscience.org/library/papers/23812729 | PubMed |
| 14 | 33390785 | The expression and clinical significance of TPM4 in hepatocellular carcinoma. | Int J Med Sci | 2021 | https://conductscience.org/library/papers/33390785 | PubMed |
| 15 | 35986010 | Exosomal miR-155-5p derived from glioma stem-like cells promotes mesenchymal transition via targeting ACOT12. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35986010 | PubMed |
| 16 | 25712463 | Myosin motor isoforms direct specification of actomyosin function by tropomyosins. | Cytoskeleton (Hoboken) | 2015 | https://conductscience.org/library/papers/25712463 | PubMed |
| 17 | 24858041 | A cadherin switch underlies malignancy in high-grade gliomas. | Oncogene | 2015 | https://conductscience.org/library/papers/24858041 | PubMed |
| 18 | 32432739 | TPM4 aggravates the malignant progression of hepatocellular carcinoma through negatively regulating SUSD2. | Eur Rev Med Pharmacol Sci | 2020 | https://conductscience.org/library/papers/32432739 | PubMed |
| 19 | 29186115 | A transfer-RNA-derived small RNA regulates ribosome biogenesis. | Nature | 2017 | https://conductscience.org/library/papers/29186115 | PubMed |
| 20 | 26703738 | tRNA-Derived Fragments (tRFs): Emerging New Roles for an Ancient RNA in the Regulation of Gene Expression. | Life (Basel) | 2015 | https://conductscience.org/library/papers/26703738 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42882926 | Uncovering the Role of Small and Intermediate-Length Non-Coding RNAs in Glioma Pathogenesis and Prognosis. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42882926 | PubMed |
| 42524343 | tsRNA's Biological Function and its Potential Application in Disease Diagnosis and Prognosis. | J Cancer | 2026 | https://conductscience.org/library/papers/42524343 | PubMed |
| 42521835 | tRF-27-87R8WP9N1E5 serves as a prognostic biomarker and tumor suppressor in gastric cancer by targeting the WNT4 pathway via Ago2. | Oncogene | 2026 | https://conductscience.org/library/papers/42521835 | PubMed |
| 42415015 | Serum 5'-tiRNA-iMet-CAT is a novel biomarker for the diagnosis and early postoperative assessment of hepatocellular carcinoma. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/42415015 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TPM4 | 7171 | PubTator's text mining | https://conductscience.org/library/genes/7171 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40202170
GET https://conductscience.org/api/papers/v1/40202170/references?page=2